NSHBY yields 2.50% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, NSHBY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NSHBY + MRK for your $10,000?
Nisshinbo Holdings Inc., together with its subsidiaries, engages in the wireless and communications, micro devices, automobile brakes, precision instruments, chemicals, textiles, and real estate businesses worldwide. The company offers wireless communication equipment, including disaster-prevention systems and surveillance systems, mobile communication equipment for shipping and automobiles, power-supply and energy equipment, and ultrasonic sensors; and micro devices, which include CMOS operational amplifiers, SAW filters, and MEMS microphones. It also manufactures and supplies friction materials, such as disc pads and brake linings, and drum and disc brakes for use in compact cars, ordinary passenger cars, sports cars, large trucks, and buses, as well as for repairs and tests in garages and dealers; and molding products, precision parts, and system equipment, as well as electronic brake systems. In addition, the company manufactures and supplies rigid polyurethane foam/wastewater treatment carriers; carbodilite, a high-performance resin additive; bipolar plates for fuel cells; and amorphous carbon products, as well as shirts, uniforms, mobilons/elastomers, and oikos products. Further, it redevelops unused plant sites; leases office and commercial facilities; and sells housing lots. The company was incorporated in 1907 and is headquartered in Tokyo, Japan.
Full NSHBY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.